144 related articles for article (PubMed ID: 29544572)
1. Effect of Metformin Alone Compared with Metformin Plus Simvastatin on Polycystic Ovarian Syndrome in Pakistani Women.
Malik M; Tasnim N; Mahmud G
J Coll Physicians Surg Pak; 2018 Mar; 28(3):184-187. PubMed ID: 29544572
[TBL] [Abstract][Full Text] [Related]
2. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.
Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4938-45. PubMed ID: 19890022
[TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.
Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
J Clin Endocrinol Metab; 2011 Nov; 96(11):3493-501. PubMed ID: 21865358
[TBL] [Abstract][Full Text] [Related]
4. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome.
Seyam E; Hefzy E
Gynecol Endocrinol; 2018 Dec; 34(12):1073-1080. PubMed ID: 30044162
[TBL] [Abstract][Full Text] [Related]
6. Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.
Ghazeeri G; Abbas HA; Skaff B; Harajly S; Awwad J
J Endocrinol Invest; 2015 Jun; 38(6):643-51. PubMed ID: 25722221
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.
Kazerooni T; Shojaei-Baghini A; Dehbashi S; Asadi N; Ghaffarpasand F; Kazerooni Y
Fertil Steril; 2010 Nov; 94(6):2208-13. PubMed ID: 20079899
[TBL] [Abstract][Full Text] [Related]
8. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.
Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A
Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials.
Meng J; Zhu Y
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():19-24. PubMed ID: 33338947
[TBL] [Abstract][Full Text] [Related]
11. Metformin therapy in women with polycystic ovary syndrome.
Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N
Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396
[TBL] [Abstract][Full Text] [Related]
12. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
13. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
[TBL] [Abstract][Full Text] [Related]
14. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
Kriplani A; Agarwal N
J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
18. Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome.
Iwata MC; Porquere L; Sorpreso IC; Baracat EC; Soares Júnior JM
Rev Assoc Med Bras (1992); 2015; 61(3):215-9. PubMed ID: 26248242
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]